MX2021002794A - Metodo mejorado para la fabricacion de 3-[(1s)-1-imidazo[1,2-a]pir idin-6- iletil]-5-(1-metilpirazol-4-il)triazolo[4,5-b]pirazina y formas polimorficas de la misma. - Google Patents

Metodo mejorado para la fabricacion de 3-[(1s)-1-imidazo[1,2-a]pir idin-6- iletil]-5-(1-metilpirazol-4-il)triazolo[4,5-b]pirazina y formas polimorficas de la misma.

Info

Publication number
MX2021002794A
MX2021002794A MX2021002794A MX2021002794A MX2021002794A MX 2021002794 A MX2021002794 A MX 2021002794A MX 2021002794 A MX2021002794 A MX 2021002794A MX 2021002794 A MX2021002794 A MX 2021002794A MX 2021002794 A MX2021002794 A MX 2021002794A
Authority
MX
Mexico
Prior art keywords
manufacture
methylpyrazol
ylethyl
triazolo
imidazo
Prior art date
Application number
MX2021002794A
Other languages
English (en)
Inventor
Wei Yu
Bo Liu
Andrew Roy Turner
Andrew Timothy Turner
Gareth Paul Howell
Malcolm Allan GALL
Keith Raymond Mulholland
Neil Keith Adlington
Zhenping Tian
Qisun Gong
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of MX2021002794A publication Critical patent/MX2021002794A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

Abstract

Esta memoria descriptiva se refiere generalmente a un método mejorado para la fabricación de 3-[(1S)-1-imidazo[1,2-a]piridin-6- iletil]-5-(1-metilpirazol-4-il)triazolo[4,5-b]pirazina (I), o sales farmacéuticamente aceptables de la misma; formas polimórficas de la misma; e intermedios útiles en la fabricación de dichos compuestos y sales de los mismos. (ver Fórmula).
MX2021002794A 2018-09-11 2019-09-10 Metodo mejorado para la fabricacion de 3-[(1s)-1-imidazo[1,2-a]pir idin-6- iletil]-5-(1-metilpirazol-4-il)triazolo[4,5-b]pirazina y formas polimorficas de la misma. MX2021002794A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2018104941 2018-09-11
PCT/EP2019/074083 WO2020053198A1 (en) 2018-09-11 2019-09-10 Improved method for the manufacture of 3-[(1s)-1-imidazo[1,2-a]pyridin-6-ylethyl]-5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazine and polymorphic forms thereof

Publications (1)

Publication Number Publication Date
MX2021002794A true MX2021002794A (es) 2021-08-11

Family

ID=67988964

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021002794A MX2021002794A (es) 2018-09-11 2019-09-10 Metodo mejorado para la fabricacion de 3-[(1s)-1-imidazo[1,2-a]pir idin-6- iletil]-5-(1-metilpirazol-4-il)triazolo[4,5-b]pirazina y formas polimorficas de la misma.

Country Status (15)

Country Link
US (1) US20220048904A1 (es)
EP (1) EP3849977B1 (es)
JP (1) JP2022500494A (es)
KR (1) KR20210057777A (es)
CN (1) CN112930348B (es)
AR (1) AR116312A1 (es)
AU (1) AU2019340569B2 (es)
BR (1) BR112021003814A2 (es)
CA (1) CA3110762A1 (es)
CO (1) CO2021004130A2 (es)
EA (1) EA202190643A1 (es)
ES (1) ES2956847T3 (es)
IL (1) IL281283B2 (es)
MX (1) MX2021002794A (es)
WO (1) WO2020053198A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116209754A (zh) 2020-09-28 2023-06-02 科德克希思公司 用于合成手性胺的工程化生物催化剂及方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106432225B (zh) * 2009-12-31 2019-02-19 和记黄埔医药（上海）有限公司 某些***并吡啶化合物和***并吡嗪化合物、其组合物和其使用方法

Also Published As

Publication number Publication date
AR116312A1 (es) 2021-04-21
EA202190643A1 (ru) 2021-07-09
EP3849977B1 (en) 2023-07-19
CN112930348A (zh) 2021-06-08
CA3110762A1 (en) 2020-03-19
ES2956847T3 (es) 2023-12-29
KR20210057777A (ko) 2021-05-21
CN112930348B (zh) 2023-12-05
IL281283B1 (en) 2023-09-01
TW202026295A (zh) 2020-07-16
IL281283A (en) 2021-04-29
AU2019340569A1 (en) 2021-05-13
IL281283B2 (en) 2024-01-01
WO2020053198A1 (en) 2020-03-19
AU2019340569B2 (en) 2022-06-09
CO2021004130A2 (es) 2021-04-30
EP3849977A1 (en) 2021-07-21
BR112021003814A2 (pt) 2021-05-18
US20220048904A1 (en) 2022-02-17
JP2022500494A (ja) 2022-01-04

Similar Documents

Publication Publication Date Title
CL2019000942A1 (es) Compuestos de pirazolo[1,5-a]piridina sustituidos como inhibidores de la quinasa ret.
TN2019000110A1 (en) Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitors
NZ744349A (en) Pyrazolo[1,5-a]pyrazin-4-yl derivatives as jak-inhibitors
PH12019501355A1 (en) Small molecule inhibitors of the jak family of kinases
TN2016000458A1 (en) Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer.
IL286912A (en) Process for the preparation of 4-phenyl-5-alkoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]-3-oxo-5,6,8,8a-tetrahydro-1h-imidazo[1,5-a]pyrazin-2-yl]-carboxylic acid
TN2020000195A1 (en) PROCESS FOR THE PREPARATION OF PYRAZOLO[1,5-a]PYRIMIDINES AND SALTS THEREOF
PE20161388A1 (es) Inhibidores de la jak1 para el tratamiento de sindromes mielodisplasicos
MY196260A (en) Small Molecule Inhibitors of the Jak Family Of Kinases
NZ732441A (en) Solid forms of an ask1 inhibitor
MX2015013711A (es) Novedosas n-acil-(3-sustituidas)-(8-sustituidas)-5,6-dihidro-[1,2, 4]triazolo[4,3-a]piracinas como antagonistas selecticos de receptor de nk-3, composicion farmaceutica y metodos para su uso en trastornos mediados por el receptor de nk-3.
MY190429A (en) Macrocycles with hetrocyclic p2' groups as factor xia inhibitors
MX2018005445A (es) Compuestos de imidazo[4,5-c]quinolin-2-ona y su uso en el tratamiento del cancer.
MX2017016772A (es) Metodo para producir un derivado de 7h-pirrolo[2,3-d]pirimidina e intermediario del mismo.
PE20090506A1 (es) DERIVADOS DE IMIDAZO-[1,2-b]-PIRIDAZIN COMO INHIBIDORES DE ALK5 Y/O ALK4
PH12018500957A1 (en) Imidazo[4,5-c] quinolin -2-one compounds and their use in treating cancer
MX2018003186A (es) Derivados de 8-[6-[3-(amino)propoxi]-3-piridil]1-isopropilimidazo[ 4,5-c]quinolin-2-ona como moduladores selectivos de la cinasa de la ataxia telangiectasia mutada (atm) para el tratamiento del cancer.
MX368162B (es) Derivados de pirazolo[1,5-a]pirimidina sustituida con piperidina con actividad inhibidora sobre la replicacion del virus sincicial respiratorio (vsr).
CL2016000496A1 (es) Compuestos derivados de 1,2,4-triazolo[1,5-a]-piridina, inhibidores de una janus cinasa, tal como jak1; composiciones farmacológicas; útiles para el tratamiento de enfermedades inflamatorias.
MX2018013133A (es) Compuesto de pirazolo[1,5-a]pirimidina.
MX367913B (es) Derivados de 4,5,6,7-tetrahidro-pirazolo[1,5-a]pirimidina y 2,3-dihidro-1h-imidazo[1,2-b]pirazol sustituidos como inhibidores de ros1.
NZ754944A (en) Imidazo [1,5-a] pyrazine derivatives as pi3kdelta inhibitors
MX2019007542A (es) Proceso para la preparación de derivados de 7h-pirrolo [2, 3-d] pirimidina y sus intermedios sintéticos.
MX367633B (es) Nueva sintesis quiral de n-acil-(3-sustituidas)-(8-sustituidas)-5, 6-dihidro-[1,2,4]triazolo[4,3-a]pirazinas.
MX2021002794A (es) Metodo mejorado para la fabricacion de 3-[(1s)-1-imidazo[1,2-a]pir idin-6- iletil]-5-(1-metilpirazol-4-il)triazolo[4,5-b]pirazina y formas polimorficas de la misma.